Heinrich D Luetticken

Title: Heinrich D Luetticken: Innovator in Vaccine Development

Introduction

Heinrich D Luetticken is a notable inventor based in Boxmeer, Netherlands. He has made significant contributions to the field of vaccine development, particularly in the area of infectious bursal disease viruses.

Latest Patents

Luetticken holds a patent for an "Attenuated, live vaccine for Delaware strain IBDV." This innovative vaccine involves live, attenuated Delaware infectious bursal disease viruses that are screened for effectiveness using a monoclonal antibody specific to the Delaware strain. The patent highlights that viruses not bound by the antibody may not be as effective in providing protection against homologous wild-type infectious bursal disease infection. This advancement addresses a gap in currently available live, attenuated vaccines, which do not include a virus with the specified binding site.

Career Highlights

Heinrich D Luetticken is affiliated with the University System of Maryland, where he continues to contribute to research and development in vaccine technology. His work has been instrumental in advancing the understanding and treatment of infectious diseases.

Collaborations

Luetticken has collaborated with esteemed colleagues such as David B Snyder and Vikram N Vakharia, further enhancing the impact of his research in the scientific community.

Conclusion

Heinrich D Luetticken's innovative work in vaccine development, particularly his patent for the Delaware strain IBDV vaccine, showcases his commitment to improving public health through scientific research. His contributions are vital in the ongoing fight against infectious diseases.